Lung Ultrasound to Diagnose COVID-19

Use of Lung Ultrasound in Patients Suspected of COVID-19 Infection in the Emergency Room

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04368338

Acronym

COVILUS

Enrollment

100

Registered

2020-04-29

Start date

2020-04-28

Completion date

2021-07-20

Last updated

2021-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid-19, Lung Ultrasound, Respiratory Complication

Keywords

Covid-19, lung ultrasound, Respiratory Complication

Brief summary

Covid-19 (English acronym meaning coronavirus disease 2019) is an emerging infectious disease caused by a strain of coronavirus called SARS-CoV-2. The current pandemic has resulted in a significant number of admissions in the emergency room (ER) due to suspicion of COVID-19 infection. Use of lung ultrasound is standard practice to diagnose acute respiratory failure in ER. Recently, typical lung ultrasonographic characteristics of COVID-19 disease has been described. During the COVID-19 pandemic, the use of this tool could be of interest in order to allow an early, simple and reliable triage in patients with suspected COVID-19 infection admitted in ER. In addition, the visualization of early signs in specific areas could be a predictive marker of the severity of the disease. The objective of this project will be to study the association between the signs on lung ultrasound and the result of RT-PCR in patients with suspected COVID-19 infection in the ER.

Interventions

DIAGNOSTIC_TESTCOVID-19 RT-PCR

Polymerase chain reaction tests after reverse transcription for the detection of viral Covid-19 RNA (RT-PCR)

PROCEDURElung ultrasound

lung ultrasound is standard practice to diagnose acute respiratory failure in Emergency room

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* patients admitted to Emergency Room for suspicion of COVID-19 infection with has a SARS-CoV-2 RT-PCR test and for whom the emergency doctor decide to perform a lung ultrasound

Exclusion criteria

* patients \< 18 years of age or under guardianship or curators, * pregnancy * poor echogenicity due to the presence of an acoustic barrier (pneumothorax, subcutaneous emphysema, etc.) * patients with a suspected or proven acute lung disease (pneumonitis, acute respiratory distress syndrome (ARDS)) * chronic interstitial lung disease * patients who will refuse to give their consent.

Design outcomes

Primary

Measure	Time frame	Description
Lung ultrasound/biological correlation research modulating the severity of Covid-19 disease	6 months	Polymerase chain reaction tests after reverse transcription for the detection of covid-19 viral RNA will be done as biological test.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026